C Caruso L Laterza C R Settanni S Colantuono C Di Mario B Tolusso F Castrì E Gremese F Scaldaferri A Armuzzi C De Simone K Peris A Chiricozzi A Gasbarrini
10.3389/fimmu.2022.995304
Front Immunol
2023 Jan 11;13:995304.
ipex (immune dysregulation x-linked) atopic dermatis biomarker cytokines dupilumab polyendocrinopathy type2
CC BY
https://pubmed.ncbi.nlm.nih.gov/36713411/
Dermatitis, Atopic Diabetes Mellitus, Type 2 Eczema / complications Eczema / diagnosis Eczema / drug therapy
Dermatitis, Atopic Diabetes Mellitus, Type 2 Eczema / complications Eczema / diagnosis Eczema / drug therapy Case Reports Humans Male Quality of Life Young Adult dupilumab Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome
PMC9875030
36713411
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
2023